Literature DB >> 2175663

Malignant giant cell tumor of bone: malignant transformation of a benign giant cell tumor treated by surgery.

X Z Zhu1, G C Steiner.   

Abstract

A case of a giant cell tumor of the right proximal femur that developed malignant change following surgical treatment ("secondary" malignant giant cell tumor) is presented. The patient had a cystic lesion that was initially interpreted as an aneurysmal bone cyst. A local recurrence six months later demonstrated the histological features of typical giant cell tumor. A further recurrence 22 months after the original treatment showed histological malignancy. Death was due to massive local recurrence and to extension of the malignancy to the pleura.

Entities:  

Mesh:

Year:  1990        PMID: 2175663

Source DB:  PubMed          Journal:  Bull Hosp Jt Dis Orthop Inst        ISSN: 0883-9344


  5 in total

1.  Treatment and outcome of malignant giant cell tumor in the spine.

Authors:  Huabin Yin; Mo Cheng; Bo Li; Binbin Li; Peng Wang; Tong Meng; Jing Wang; Wang Zhou; Wangjun Yan; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-06-04       Impact factor: 4.130

2.  Histological and clinical characteristics of malignant giant cell tumor of bone.

Authors:  Lihua Gong; Weifeng Liu; Xiaoqi Sun; Constantin Sajdik; Xinxia Tian; Xiaohui Niu; Xiaoyuan Huang
Journal:  Virchows Arch       Date:  2012-02-17       Impact factor: 4.064

Review 3.  Secondary Malignancy in Giant Cell Tumor: A Single-Center Study.

Authors:  Min Wook Joo; Yong-Suk Lee; Hong Sik Park; Yang-Guk Chung; Chiyoung Yoon
Journal:  Curr Oncol       Date:  2022-06-02       Impact factor: 3.109

4.  Case report: two-step malignant transformation of a liposclerosing myxofibrous tumor of bone.

Authors:  Kirk Campbell; Felasfa Wodajo
Journal:  Clin Orthop Relat Res       Date:  2008-07-08       Impact factor: 4.176

5.  Spontaneous malignant transformation of conventional giant cell tumor.

Authors:  H J Grote; M Braun; T Kalinski; N Pomjanski; W Back; U Bleyl; A Böcking; A Roessner
Journal:  Skeletal Radiol       Date:  2004-01-29       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.